JPRN-UMIN000019338已完成未知
Clinical outcome of risedronate therapy for patients with Paget's disease of bone - Clinical outcome of risedronate therapy for patients with Paget's disease of bone
agoya University Hospital0 个研究点目标入组 15 人开始时间: 2015年10月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •not tolerated for risedronate
研究者
相似试验
已完成
4 期
Efficacy of monthly sodium risedronate for the treatment of corticosteroid induced osteoporosis in patients with rheumatoid arthritis (multicenter, double-blind, randomized, placebo-controlled, parallel-group study )osteoporosis, rheumatoid arthritisJPRN-UMIN000015794Division of rheumatology, endcrinology and nephrology, Hokkaido University Graduate School of Medicine165
已完成
不适用
Effects of risedronate on the progression of aortic valv stenosis in osteoporosis patientsAortic valve stenosis with osteoporosisJPRN-UMIN000003226Juntendo University School of Medcine, The department of Cardiology180
已完成
不适用
Study on preventive effect of risedronate administration on aromatase inhibitor-induced bone mineral loss in the endoclinical therapy for postmenopausal breast cancer patientsHormone-receptor positive, postmenopausal primary breast cancerJPRN-UMIN000004375Graduate School of Medicine Kyoto University64
已完成
不适用
Randomized phase II/III study of Risedronate in combination with Docetaxel versus Docetaxel alone in patients with hormone refractory prostate cancerMalignant neoplasm of prostateProstate CancerCancerISRCTN22844568Erasmus Medical Centre (Netherlands)480
招募中
3 期
Investigation of the efficacy of Risperidone in the treatment of developmental stuttering in Persian-speaking children aged 5 to 10 yearsStuttering.Childhood onset fluency disorderF80.81IRCT20240527061909N1Babol University of Medical Sciences30